Cargando…

Potential Role of Atrial Myopathy in the Pathogenesis of Stroke in Rheumatoid Arthritis and Psoriasis: A Conceptual Framework and Implications for Prophylaxis

Detalles Bibliográficos
Autor principal:	Packer, Milton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033881/ https://www.ncbi.nlm.nih.gov/pubmed/31973602 http://dx.doi.org/10.1161/JAHA.119.014764

Ejemplares similares

Characterization, Pathogenesis, and Clinical Implications of Inflammation‐Related Atrial Myopathy as an Important Cause of Atrial Fibrillation
por: Packer, Milton
Publicado: (2020)

Molecular, Cellular, and Clinical Evidence That Sodium‐Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart Failure
por: Packer, Milton
Publicado: (2020)

COVID‐19, Social Determinants of Health, and Opportunities for Preventing Cardiovascular Disease: A Conceptual Framework
por: Russo, Rienna G., et al.
Publicado: (2021)

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Collado, Fareed Moses S., et al.
Publicado: (2021)

Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
por: Cao, Lin, et al.
Publicado: (2015)

Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review
por: Kotadia, Irum D., et al.
Publicado: (2021)

Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes
por: Gaudino, Mario, et al.
Publicado: (2019)

Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?
por: Lip, Gregory Y. H., et al.
Publicado: (2014)

An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
por: Cove, Christina L., et al.
Publicado: (2013)

Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018)

Effect of a Clinical Pharmacy Education Program on Improvement in the Quantity and Quality of Venous Thromboembolism Prophylaxis for Medically Ill Patients
por: Dobesh, Paul P., et al.
Publicado: (2005)

Exploring Refractoriness as an Adjunctive Electrical Biomarker for Staging of Atrial Fibrillation
por: van Staveren, Lianne N., et al.
Publicado: (2020)

Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019
por: Rattanawong, Pattara, et al.
Publicado: (2020)

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
por: Di Biase, Luigi
Publicado: (2016)

Traversing the Quality Chasm: Revisiting the Framework for Pharmacy Services Quality Improvement
por: Nelson, Mel L., et al.
Publicado: (2020)

Stroke–Heart Syndrome: Recent Advances and Challenges
por: Scheitz, Jan F., et al.
Publicado: (2022)

Using Mobile Technology for Cardiac Rehabilitation: A Review and Framework for Development and Evaluation
por: Beatty, Alexis L., et al.
Publicado: (2013)

Framework for Pharmacy Services Quality Improvement-A Bridge to Cross the Quality Chasm
por: Curtiss, Frederic R., et al.
Publicado: (2004)

Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
por: Derex, Laurent, et al.
Publicado: (2018)

Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders
por: Collado, Fareed Moses S., et al.
Publicado: (2018)

Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
por: Miao, Lina, et al.
Publicado: (2023)

Change of Heart: The Underexplored Role of Plaque Hemorrhage in the Evaluation of Stroke of Undetermined Etiology
por: Holmes, David R., et al.
Publicado: (2022)

Blood–Brain Barrier Disruption, Vascular Impairment, and Ischemia/Reperfusion Damage in Diabetic Stroke
por: Venkat, Poornima, et al.
Publicado: (2017)

COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
por: Mitrani, Raul D., et al.
Publicado: (2020)

Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications
por: Tzamaloukas, Antonios H., et al.
Publicado: (2019)

Rheumatoid Arthritis and Psoriasis Vulgaris
por: Boisvert, Paul L.
Publicado: (1956)

Summary Report of the Arthritis Foundation and the American Orthopaedic Foot & Ankle Society’s Symposium on Targets for Osteoarthritis Research: Part 2: Treatment Options
por: Kim, Jason S., et al.
Publicado: (2022)

Risk Stratification Tools to Guide a Personalized Approach for Cardiac Monitoring in Embolic Stroke of Undetermined Source
por: Louka, Anna Maria, et al.
Publicado: (2023)

What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
por: Feigin, Valery L., et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID‐19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease
por: Alsaied, Tarek, et al.
Publicado: (2020)

Neurohormonal Regulation of I(Ks) in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac Death
por: Shugg, Tyler, et al.
Publicado: (2020)

Renin‐Angiotensin System Blockade in Aortic Stenosis: Implications Before and After Aortic Valve Replacement
por: Goel, Sachin S., et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
por: Ortega‐Paz, Luis, et al.
Publicado: (2021)

Summary Report of the Arthritis Foundation and the American Orthopaedic Foot & Ankle Society’s Symposium on Targets for Osteoarthritis Research: Part 1: Epidemiology, Pathophysiology, and Current Imaging Approaches
por: Kim, Jason S., et al.
Publicado: (2022)

Vascular Smooth Muscle Cells in Aortic Aneurysm: From Genetics to Mechanisms
por: Lu, Haocheng, et al.
Publicado: (2021)

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers
por: Walden, Daniel C., et al.
Publicado: (2003)

Metabolic Profiling in Rheumatoid Arthritis, Psoriatic Arthritis, and Psoriasis: Elucidating Pathogenesis, Improving Diagnosis, and Monitoring Disease Activity
por: Dorochow, Erika, et al.
Publicado: (2022)

RHEUMATOID FACTOR AND THE PATHOGENESIS OF RHEUMATOID ARTHRITIS
por: Mellors, Robert C., et al.
Publicado: (1961)

Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failure
por: Packer, Milton
Publicado: (2020)

Epigenetics in the pathogenesis of rheumatoid arthritis
por: Glant, Tibor T, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rbf3lgtd8is7nrjs1tqp5g8794